BioMarin Pharmaceutical Inc. provided financial guidance for 2023. For the period, the company expects Total Revenues to be $2,375 million to $2,500 million. GAAP Net Income $155 million to $205 million.

GAAP Diluted EPS $0.78 to $1.03.